These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4484532)

  • 1. Anticoagulant activity of two commercially available heparin preparations. A controlled study.
    Gomez-Perez F
    J Clin Pharmacol New Drugs; 1972 Oct; 12(10):413-6. PubMed ID: 4484532
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of anticoagulant activity of two preparations of purified heparin.
    Baltes BJ; Diamond S; D'Agostino RJ
    Clin Pharmacol Ther; 1973; 14(2):287-90. PubMed ID: 4735188
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant activities of lung and mucous heparins.
    Barrowcliffe TW; Johnson EA; Eggleton CA; Thomas DP
    Thromb Res; 1978 Jan; 12(1):27-36. PubMed ID: 644557
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticoagulant activity of whale intestine heparin and its clinical application.
    Abe T; Kazama M; Matsuda M; Ikemori R; Shibata T
    Bibl Haematol; 1968; 29():1141-9. PubMed ID: 5750138
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative evaluation of the anticoagulant activity of the sodium and calcium salts of heparin, isolated from swine intestinal mucosa].
    Ushkalova EA; Kremneva VF; Ovchinnikova LK; Shcheglova NV
    Farmakol Toksikol; 1989; 52(3):51-5. PubMed ID: 2792354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM; Capillé NV; Santos GR; Vairo BC; Oliveira SN; Fonseca RJ; Mourão PA
    Thromb Haemost; 2012 May; 107(5):903-15. PubMed ID: 22437650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulant potency of mucosal and lung heparin.
    McMahon FG; Jain AK; Ryan JR; Lefton TE
    Clin Pharmacol Ther; 1975 Jan; 17(1):79-82. PubMed ID: 1168110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular weight dependence of the anticoagulant properties of heparin: intravenous and subcutaneous administration of fractionated heparins to man.
    Lane DA; MacGregor IR; VanRoss M; Cella G; Kakkar VV
    Thromb Res; 1979; 16(5-6):651-62. PubMed ID: 524315
    [No Abstract]   [Full Text] [Related]  

  • 9. The heterogeneity of heparins.
    Lasker SE
    Fed Proc; 1977 Jan; 36(1):92-7. PubMed ID: 556607
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties.
    Holmer E; Söderberg K; Bergqvist D; Lindahl U
    Haemostasis; 1986; 16 Suppl 2():1-7. PubMed ID: 3744129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heparin therapy.
    Raich PC; Hahn MF; Korst DR
    Am Fam Physician; 1974 Sep; 10(3):163-8. PubMed ID: 4413661
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticoagulant activity of beef and hog mucosal heparins.
    Aiach M; Kher A; Michaud A; Mardiguian J; Trillou M; Leclerc M
    Thromb Res; 1979 Jan; 14(1):167-77. PubMed ID: 371063
    [No Abstract]   [Full Text] [Related]  

  • 13. Heparin therapy by continuous intravenous infusion.
    Swanson M; Cacace L
    Am J Hosp Pharm; 1971 Oct; 28(10):792-5. PubMed ID: 5125174
    [No Abstract]   [Full Text] [Related]  

  • 14. Kinetics of heparin administration.
    Perry MO; Horton J
    Arch Surg; 1976 Apr; 111(4):403-9. PubMed ID: 1259578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new route of heparin administration--the lung.
    Kavanagh LW; Jaques LB
    Arzneimittelforschung; 1976; 26(3):389-92. PubMed ID: 989334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of heparin on the activated partial thromboplastin time.
    Triplett DA; Harms CS; Koepke JA
    Am J Clin Pathol; 1978 Sep; 70(3 Suppl):556-9. PubMed ID: 568381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A train difference in anticoagulant response to subcutaneous administration of heparin in mice.
    Sue TK; Jaques LB; Yelland J
    Thromb Res; 1978 Jan; 12(1):5-13. PubMed ID: 644560
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro comparative study of the anticoagulant action of lung and gut heparin: part 1.
    Fukuda T; Tatsumi Y; Kimura Y; Maeda H; Okuda K
    Osaka City Med J; 1980; 26(1):19-37. PubMed ID: 7267090
    [No Abstract]   [Full Text] [Related]  

  • 20. Thromboelastographic modifications induced by intravenous and subcutaneous heparin administration.
    Traverso CI; Caprini JA; Arcelus JI; Arcelus IM
    Semin Thromb Hemost; 1995; 21 Suppl 4():53-8. PubMed ID: 8747689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.